Recalls & Warnings October 22, 2019 Company Marketing CBD for Use in Infants and Children Gets Strong Warning On October 10, 2019, the FDA and FTC issued a joint warning letter to Rooted Apothecary LLC for "illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims" including that the products could treat teething pain and ear aches in infants, autism,
Khavinson VK, Razumovskii MI, Trofimova SV, Grigoryan RA, Chaban TV, Oleinik TL, et al
As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment
JAMA 278:144151 Amato L, Minozzi S, Davoli M (2011) Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome